119 related articles for article (PubMed ID: 38401121)
1. PRMT1 acts as a suppressor of MHC-I and anti-tumor immunity.
Djajawi TM; Pijpers L; Srivaths A; Chisanga D; Chan KF; Hogg SJ; Neil L; Rivera SM; Bartonicek N; Ellis SL; Lim Kam Sian TCC; Faridi P; Liao Y; Pal B; Behren A; Shi W; Vervoort SJ; Johnstone RW; Kearney CJ
Cell Rep; 2024 Mar; 43(3):113831. PubMed ID: 38401121
[TBL] [Abstract][Full Text] [Related]
2. PRMT1 Inhibition Activates the Interferon Pathway to Potentiate Antitumor Immunity and Enhance Checkpoint Blockade Efficacy in Melanoma.
Tao H; Jin C; Zhou L; Deng Z; Li X; Dang W; Fan S; Li B; Ye F; Lu J; Kong X; Liu C; Luo C; Zhang Y
Cancer Res; 2024 Feb; 84(3):419-433. PubMed ID: 37991725
[TBL] [Abstract][Full Text] [Related]
3. PRMT1-mediated arginine methylation of PIAS1 regulates STAT1 signaling.
Weber S; Maass F; Schuemann M; Krause E; Suske G; Bauer UM
Genes Dev; 2009 Jan; 23(1):118-32. PubMed ID: 19136629
[TBL] [Abstract][Full Text] [Related]
4. Protein arginine methyltransferase 1 (PRMT1) represses MHC II transcription in macrophages by methylating CIITA.
Fan Z; Li J; Li P; Ye Q; Xu H; Wu X; Xu Y
Sci Rep; 2017 Jan; 7():40531. PubMed ID: 28094290
[TBL] [Abstract][Full Text] [Related]
5. PRMT1 regulates tumor growth and metastasis of human melanoma via targeting ALCAM.
Li L; Zhang Z; Ma T; Huo R
Mol Med Rep; 2016 Jul; 14(1):521-8. PubMed ID: 27175582
[TBL] [Abstract][Full Text] [Related]
6. PRMT1 inhibition promotes ferroptosis sensitivity via ACSL1 upregulation in acute myeloid leukemia.
Zhou L; Jia X; Shang Y; Sun Y; Liu Z; Liu J; Jiang W; Deng S; Yao Q; Chen J; Li H
Mol Carcinog; 2023 Aug; 62(8):1119-1135. PubMed ID: 37144835
[TBL] [Abstract][Full Text] [Related]
7. Natural Killer Cells Suppress T Cell-Associated Tumor Immune Evasion.
Freeman AJ; Vervoort SJ; Ramsbottom KM; Kelly MJ; Michie J; Pijpers L; Johnstone RW; Kearney CJ; Oliaro J
Cell Rep; 2019 Sep; 28(11):2784-2794.e5. PubMed ID: 31509742
[TBL] [Abstract][Full Text] [Related]
8. Constitutive high expression of protein arginine methyltransferase 1 in asthmatic airway smooth muscle cells is caused by reduced microRNA-19a expression and leads to enhanced remodeling.
Sun Q; Liu L; Wang H; Mandal J; Khan P; Hostettler KE; Stolz D; Tamm M; Molino A; Lardinois D; Lu S; Roth M
J Allergy Clin Immunol; 2017 Aug; 140(2):510-524.e3. PubMed ID: 28081849
[TBL] [Abstract][Full Text] [Related]
9. Lactate induced HIF-1α-PRMT1 cross talk affects MHC I expression in monocytes.
Gupta P; Singh A; Gowda P; Ghosh S; Chatterjee A; Sen E
Exp Cell Res; 2016 Oct; 347(2):293-300. PubMed ID: 27521225
[TBL] [Abstract][Full Text] [Related]
10. Protein arginine methyltransferase 1 is a therapeutic vulnerability in multiple myeloma.
Nguyen HP; Le AQ; Liu E; Cesarano A; DiMeo F; Perna F; Kapur R; Walker BA; Tran NT
Front Immunol; 2023; 14():1239614. PubMed ID: 37600810
[TBL] [Abstract][Full Text] [Related]
11. The role of PRMT1 in EGFR methylation and signaling in MDA-MB-468 triple-negative breast cancer cells.
Nakai K; Xia W; Liao HW; Saito M; Hung MC; Yamaguchi H
Breast Cancer; 2018 Jan; 25(1):74-80. PubMed ID: 28643125
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of human protein arginine methyltransferase 1(PRMT1) in vivo.
Herrmann F; Lee J; Bedford MT; Fackelmayer FO
J Biol Chem; 2005 Nov; 280(45):38005-10. PubMed ID: 16159886
[TBL] [Abstract][Full Text] [Related]
13. Arginine methylation catalyzed by PRMT1 is required for B cell activation and differentiation.
Infantino S; Light A; O'Donnell K; Bryant V; Avery DT; Elliott M; Tangye SG; Belz G; Mackay F; Richard S; Tarlinton D
Nat Commun; 2017 Oct; 8(1):891. PubMed ID: 29026071
[TBL] [Abstract][Full Text] [Related]
14. Arginine methylation-dependent regulation of ASK1 signaling by PRMT1.
Cho JH; Lee MK; Yoon KW; Lee J; Cho SG; Choi EJ
Cell Death Differ; 2012 May; 19(5):859-70. PubMed ID: 22095282
[TBL] [Abstract][Full Text] [Related]
15. PRMT1-mediated FLT3 arginine methylation promotes maintenance of FLT3-ITD
He X; Zhu Y; Lin YC; Li M; Du J; Dong H; Sun J; Zhu L; Wang H; Ding Z; Zhang L; Zhang L; Zhao D; Wang Z; Wu H; Zhang H; Jiang W; Xu Y; Jin J; Shen Y; Perry J; Zhao X; Zhang B; Liu S; Xue SL; Shen B; Chen CW; Chen J; Khaled S; Kuo YH; Marcucci G; Luo Y; Li L
Blood; 2019 Aug; 134(6):548-560. PubMed ID: 31217189
[TBL] [Abstract][Full Text] [Related]
16. PRMT1 Is a Novel Regulator of Epithelial-Mesenchymal-Transition in Non-small Cell Lung Cancer.
Avasarala S; Van Scoyk M; Karuppusamy Rathinam MK; Zerayesus S; Zhao X; Zhang W; Pergande MR; Borgia JA; DeGregori J; Port JD; Winn RA; Bikkavilli RK
J Biol Chem; 2015 May; 290(21):13479-89. PubMed ID: 25847239
[TBL] [Abstract][Full Text] [Related]
17. CARM1 and PRMT1 are dysregulated in lung cancer without hierarchical features.
Elakoum R; Gauchotte G; Oussalah A; Wissler MP; Clément-Duchêne C; Vignaud JM; Guéant JL; Namour F
Biochimie; 2014 Feb; 97():210-8. PubMed ID: 24211191
[TBL] [Abstract][Full Text] [Related]
18. PRMT1 arginine methyltransferase accumulates in cytoplasmic bodies that respond to selective inhibition and DNA damage.
Suchánková J; Legartová S; Sehnalová P; Kozubek S; Valente S; Labella D; Mai A; Eckerich C; Fackelmayer FO; Sorokin DV; Bartova E
Eur J Histochem; 2014 May; 58(2):2389. PubMed ID: 24998928
[TBL] [Abstract][Full Text] [Related]
19. Methylation of C/EBPα by PRMT1 Inhibits Its Tumor-Suppressive Function in Breast Cancer.
Liu LM; Sun WZ; Fan XZ; Xu YL; Cheng MB; Zhang Y
Cancer Res; 2019 Jun; 79(11):2865-2877. PubMed ID: 31015230
[TBL] [Abstract][Full Text] [Related]
20. Deep Protein Methylation Profiling by Combined Chemical and Immunoaffinity Approaches Reveals Novel PRMT1 Targets.
Hartel NG; Chew B; Qin J; Xu J; Graham NA
Mol Cell Proteomics; 2019 Nov; 18(11):2149-2164. PubMed ID: 31451547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
